id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-D-0065-0005,FDA,FDA-1999-D-0065,Reviewer Guidance Evaluating the Risks of Drug Exposure in Human Pregnancies,Supporting & Related Material,Guidance,2005-04-28T04:00:00Z,2005,4,,,2025-06-03T16:08:44Z,,0,0,09000064804a67c0
FDA-1999-D-0065-0006,FDA,FDA-1999-D-0065,Guidance for Reviewers on Evaluating the Risks of Drug Exposure in Human Pregnancies; Availability,Notice,Notice of Data Availability,2005-04-28T04:00:00Z,2005,4,2005-04-27T04:00:00Z,,2025-06-03T16:15:30Z,05-8466,0,0,09000064804a67c1
FDA-1999-D-0065-0004,FDA,FDA-1999-D-0065,Reviewer Guidance Evaluating the Risks of Drug Exposure in Human Pregnancies,Supporting & Related Material,Guidance,2005-04-28T04:00:00Z,2005,4,,,2025-06-03T16:05:03Z,,0,0,09000064804a67bf